Literature DB >> 25043478

Protein tyrosine phosphatase receptor R and Z1 expression as independent prognostic indicators in oral squamous cell carcinoma.

Kamila Duś-Szachniewicz1, Marta Woźniak1, Kamil Nelke2, Elżbieta Gamian1, Hanna Gerber2, Piotr Ziółkowski1.   

Abstract

BACKGROUND: The actions of tyrosine phosphorylation and dephosphorylation are controlled by tyrosine kinases and phosphatases. Although substantial previous data have revealed the role of several protein tyrosine phosphatases (PTPs) in various cancers, the function of protein tyrosine phosphatase receptor R (PTPRR) and protein tyrosine phosphatase, receptor-type, Z polypeptide 1 (PTPRZ1) proteins in oral cavity squamous cell carcinoma (SCC) has not been studied to date.
METHODS: The PTPRR and PTPRZ1 immunoreactivity in 67 formalin-fixed and paraffin-embedded oral cancer tissues at different stages were analyzed with the technique of immunohistochemistry (IHC). The presence of PTPRR in cancerous tissue was confirmed by Western blotting.
RESULTS: The occurrence of PTPRR and PTPRZ1 proteins in the cancer specimens was more frequent in lower grade tumors. In addition, the association between the immunoreactivity of both examined proteins and improved patients survival was detected. Moreover, the PTPRR expression was found to be related to the absence of synchronous lymph node involvement.
CONCLUSION: The above results indicate that the PTPRR and PTPRZ1 protein expression should be monitored in oral cancer for patients' prognostic stratification.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Western blot analysis; immunohistochemistry; oral cavity squamous cell carcinoma (SSC); protein tyrosine phosphatase receptor R and Z1; protein tyrosine phosphatases (PTPs)

Mesh:

Substances:

Year:  2015        PMID: 25043478     DOI: 10.1002/hed.23835

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  8 in total

1.  Identification of PTPRR and JAG1 as key genes in castration-resistant prostate cancer by integrated bioinformatics methods.

Authors:  Ji-Li Wang; Yan Wang; Guo-Ping Ren
Journal:  J Zhejiang Univ Sci B       Date:  2020 Mar.       Impact factor: 3.066

2.  Inferring novel genes related to oral cancer with a network embedding method and one-class learning algorithms.

Authors:  Lei Chen; Yu-Hang Zhang; Guohua Huang; Xiaoyong Pan; Tao Huang; Yu-Dong Cai
Journal:  Gene Ther       Date:  2019-08-27       Impact factor: 5.250

3.  Inhibition of microRNA-15b-5p Attenuates the Progression of Oral Squamous Cell Carcinoma via Modulating the PTPN4/STAT3 Axis.

Authors:  Xuerong Liu; Yuanyuan Dong; Dan Song
Journal:  Cancer Manag Res       Date:  2020-10-28       Impact factor: 3.989

4.  Protein tyrosine phosphatase receptor type R (PTPRR) antagonizes the Wnt signaling pathway in ovarian cancer by dephosphorylating and inactivating β-catenin.

Authors:  Yuetong Wang; Jian Cao; Weiwei Liu; Jiali Zhang; Zuo Wang; Yiqun Zhang; Linjun Hou; Shengmiao Chen; Piliang Hao; Liye Zhang; Min Zhuang; Yang Yu; Dake Li; Gaofeng Fan
Journal:  J Biol Chem       Date:  2019-10-25       Impact factor: 5.157

5.  Androgen-regulation of the protein tyrosine phosphatase PTPRR activates ERK1/2 signalling in prostate cancer cells.

Authors:  Jennifer Munkley; Nicholas P Lafferty; Gabriela Kalna; Craig N Robson; Hing Y Leung; Prabhakar Rajan; David J Elliott
Journal:  BMC Cancer       Date:  2015-01-16       Impact factor: 4.430

6.  Overexpression of PTPRZ1 Regulates p120/β-Catenin Phosphorylation to Promote Carcinogenesis of Oral Submucous Fibrosis.

Authors:  Liwei Ma; Ting Shen; Hui Peng; Jianjun Wu; Wenjin Wang; Xing Gao
Journal:  J Oncol       Date:  2022-02-23       Impact factor: 4.375

7.  Protein Tyrosine Phosphatase Receptor Type R (PTPRR) Reduces AChR Clustering by Dephosphorylating MuSK.

Authors:  Yanxun Chen; Maohao Guan; Fengqiang Yu; Zhongshan Yang; Weiqiang Yi; Xuan Huang; Ruiqin Qiu; Fancai Lai
Journal:  Dis Markers       Date:  2022-09-05       Impact factor: 3.464

8.  Identification of a Five-mRNA Signature as a Novel Potential Prognostic Biomarker for Glioblastoma by Integrative Analysis.

Authors:  Huifang Xu; Linfang Zhang; Xiujuan Xia; Wei Shao
Journal:  Front Genet       Date:  2022-07-08       Impact factor: 4.772

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.